A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions

Virchows Archiv

Volumn 461, Issue 1, 2012, Pages 67-78

  Pedeutour, Florence ^a,b   Maire, Georges ^c   Pierron, Anne ^a   Thomas, David M ^d   Garsed, Dale W ^d,e   Bianchini, Laurence ^a   Duranton Tanneur, Valérie ^b   Cortes Maurel, Annabelle ^b   Italiano, Antoine ^f   Squire, Jeremy A ^c,g   Coindre, Jean Michel ^f  

^a UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c QUEEN S UNIVERSITY   (Canada)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f INSTITUT BERGONIÉ   (France)

^g National Cancer Institute of Canada Clinical Trials Group   (Canada)

Author keywords

Amplification; Cell line; HMGA2; Liposarcoma; MDM2; MLLT10

Indexed keywords

CHIMERIC PROTEIN; CYCLIN DEPENDENT KINASE 4; HIGH MOBILITY GROUP A2 PROTEIN; LYMPHOCYTE ANTIGEN; MESSENGER RNA; PROTEIN MDM2;

ADULT; AMPLICON; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER CELL CULTURE; CANCER RECURRENCE; CASE REPORT; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CENTROMERE; CHROMOSOME 10P; CHROMOSOME 12Q; CHROMOSOME DISORDER; CHROMOSOME PAINTING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DEDIFFERENTIATED LIPOSARCOMA; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; LEG SWELLING; LIPOSARCOMA; MALE; MARKER CHROMOSOME; METAPHASE CHROMOSOME; MITOSIS; MUSCLE TUMOR; ONCOGENE; PRIMARY CELL CULTURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; SPECTRAL KARYOTYPING; SPINDLE CELL; THIGH; TRIPLOIDY; TUMOR NECROSIS; WELL DIFFERENTIATED LIPOSARCOMA;

ADULT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 12; COMPARATIVE GENOMIC HYBRIDIZATION; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LIPOSARCOMA; MALE; PRIMARY CELL CULTURE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864282155     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1256-5     Document Type: Article

References (72)

1. Fletcher C, Unni K, Mertens F (2002) World Health Organization classification of tumours pathology and genetics of tumours of soft tissue and bone. Lyon
2. F Pedeutour G Maire N Sirvent 2004 From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors Bull Cancer 91 4 317 323 15242313 1:CAS:528:DC%2BD2MXjsFKrt78%3D
3. Enzinger, Weiss SW, Goldblum JR (2008) Liposarcoma. In: Elsevier M (ed) Soft tissue tumors (5th ed). St. Louis, pp. 477-516
4. JM Coindre F Pedeutour A Aurias 2009 Well-differentiated and dedifferentiated liposarcomas Virchows Arch 456 2 167 179 19688222 10.1007/s00428-009-0815-x
5. F Pedeutour A Forus JM Coindre JM Berner G Nicolo JF Michiels P Terrier D Ranchere-Vince F Collin O Myklebost C Turc-Carel 1999 Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors Genes Chromosomes Cancer 24 1 30 41 9892106 10.1002/(SICI)1098-2264(199901)24:1<30: :AID-GCC5>3.0.CO;2-P 1:STN:280:DyaK1M7gslWhtg%3D%3D
6. A Italiano L Bianchini F Keslair S Bonnafous N Cardot-Leccia JM Coindre JM Dumollard P Hofman A Leroux C Mainguene I Peyrottes D Ranchere-Vince P Terrier A Tran P Gual F Pedeutour 2008 HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon Int J Cancer 122 10 2233 2241 18214854 10.1002/ijc.23380 1:CAS:528:DC%2BD1cXkslynsLw%3D
7. A Italiano L Bianchini E Gjernes F Keslair D Ranchere-Vince JM Dumollard J Haudebourg A Leroux C Mainguene P Terrier F Chibon JM Coindre F Pedeutour 2009 Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas Clin Cancer Res 15 18 5696 5703 19737942 10.1158/1078-0432.CCR-08-3185 1:CAS:528:DC%2BD1MXhtFars7zP
8. J Barretina BS Taylor S Banerji AH Ramos M Lagos-Quintana PL Decarolis K Shah ND Socci BA Weir A Ho DY Chiang B Reva CH Mermel G Getz Y Antipin R Beroukhim JE Major C Hatton R Nicoletti M Hanna T Sharpe TJ Fennell K Cibulskis RC Onofrio T Saito N Shukla C Lau S Nelander SJ Silver C Sougnez A Viale W Winckler RG Maki LA Garraway A Lash H Greulich DE Root WR Sellers GK Schwartz CR Antonescu ES Lander HE Varmus M Ladanyi C Sander M Meyerson S Singer 2010 Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy Nat Genet 42 8 715 721 20601955 10.1038/ng.619 1:CAS:528: DC%2BC3cXotlWktLY%3D
9. MR Erickson-Johnson AR Seys CW Roth AA King RL Hulshizer X Wang YW Asmann RV Lloyd EK Jacob AM Oliveira 2009 Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma Mod Pathol 22 12 1541 1547 19820690 10.1038/modpathol.2009.149 1:CAS:528:DC%2BD1MXhsV2hu7bL
10. X Wang YW Asmann MR Erickson-Johnson JL Oliveira H Zhang RD Moura AJ Lazar D Lev K Bill RV Lloyd MJ Yaszemski A Maran AM Oliveira 2011 High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma Genes Chromosomes Cancer 50 11 849 858 21793095 10.1002/gcc.20906 1:CAS:528:DC%2BC3MXhtFCmu77N
11. I Scheinin S Myllykangas I Borze T Bohling S Knuutila J Saharinen 2008 CanGEM: mining gene copy number changes in cancer Nucleic Acids Res 36 D830 D835 17932056 10.1093/nar/gkm802 1:CAS:528:DC%2BD1cXhtVSqsbY%3D Database issue
12. M Baudis 2007 Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data BMC Cancer 7 226 18088415 10.1186/1471-2407-7-226
13. F Pedeutour RF Suijkerbuijk A Forus J Van Gaal W Van de Klundert JM Coindre G Nicolo F Collin U Van Haelst K Huffermann, et al. 1994 Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma Genes Chromosomes Cancer 10 2 85 94 7520271 10.1002/gcc.2870100203 1:CAS:528:DyaK2MXjsVCntg%3D%3D
14. D Gisselsson M Hoglund F Mertens F Mitelman N Mandahl 1998 Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization Genes Chromosomes Cancer 23 3 203 212 9790500 10.1002/(SICI)1098-2264(199811)23:3<203::AID-GCC1>3.0.CO;2-5 1:CAS:528:DyaK1cXmvFGrt74%3D
15. N Sirvent A Forus W Lescaut F Burel S Benzaken M Chazal A Bourgeon JR Vermeesch O Myklebost C Turc-Carel N Ayraud JM Coindre F Pedeutour 2000 Characterization of centromere alterations in liposarcomas Genes Chromosomes Cancer 29 2 117 129 10959091 10.1002/1098-2264(2000)9999:9999<::AID- GCC1014>3.0.CO;2-Q 1:CAS:528:DC%2BD3cXntVWiuro%3D
16. AP Dei Tos C Doglioni S Piccinin R Sciot A Furlanetto M Boiocchi P Dal Cin R Maestro CD Fletcher G Tallini 2000 Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours J Pathol 190 5 531 536 10727978 10.1002/(SICI)1096-9896(200004)190:5<531:: AID-PATH579>3.0.CO;2-W 1:CAS:528:DC%2BD3cXivVSrt7g%3D
17. F Chibon O Mariani J Derre S Malinge JM Coindre L Guillou R Lagace A Aurias 2002 A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas Cancer Genet Cytogenet 139 1 24 29 12547153 10.1016/S0165-4608(02)00614-3 1:CAS:528:DC%2BD3sXltlWrsw%3D%3D
18. F Micci MR Teixeira B Bjerkehagen S Heim 2002 Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH Cytogenet Genome Res 97 1-2 13 19 12438732 10.1159/000064038 1:CAS:528:DC%2BD38Xns1ejtbg%3D
19. SH Kresse JM Berner LA Meza-Zepeda SG Gregory WL Kuo JW Gray A Forus O Myklebost 2005 Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH Mol Cancer 4 39 16274472 10.1186/1476-4598-4-39
20. O Mariani C Brennetot JM Coindre N Gruel C Ganem O Delattre MH Stern A Aurias 2007 JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas Cancer Cell 11 4 361 374 17418412 10.1016/j.ccr.2007.02.007 1:CAS:528:DC%2BD2sXksFWjsrs%3D
21. JE Johnson EJ Gettings J Schwalm J Pei JR Testa S Litwin M von Mehren D Broccoli 2007 Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms Cancer Res 67 19 9221 9228 17909028 10.1158/0008-5472.CAN-07-1133 1:CAS:528:DC%2BD2sXhtFSnurzJ
22. WD Tap FC Eilber C Ginther SM Dry N Reese K Barzan-Smith HW Chen H Wu FR Eilber DJ Slamon L Anderson 2011 Evaluation of well-differentiated/de- differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization Genes Chromosomes Cancer 50 2 95 112 21117066 10.1002/gcc.20835 1:CAS:528:DC%2BC3cXhsFaqsLjI
23. A Italiano G Maire N Sirvent PA Nuin F Keslair C Foa C Louis A Aurias F Pedeutour 2009 Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas Cancer Lett 273 2 323 330 18823700 10.1016/j.canlet.2008.08.025 1:CAS:528:DC%2BD1cXhsV2gtbjO
24. Italiano A, Toulmonde M, Cioffi A, Penel N, Isambert N, Bompas E, Duffaud F, Patrikidou A, Lortal B, Le Cesne A, Blay JY, Maki RG, Schwartz GK, Antonescu CR, Singer S, Coindre JM, Bui B (2012) Advanced well-differentiated/ dedifferentiated liposarcomas: role of chemotherapy and survival. J Ann Oncol 23(6):1601-1607
25. CR Muller EB Paulsen P Noordhuis F Pedeutour G Saeter O Myklebost 2007 Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A Int J Cancer 121 1 199 205 17354236 10.1002/ijc.22643 1:CAS:528:DC%2BD2sXlsVajs7g%3D
26. S Singer ND Socci G Ambrosini E Sambol P Decarolis Y Wu R O'Connor R Maki A Viale C Sander GK Schwartz CR Antonescu 2007 Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma Cancer Res 67 14 6626 6636 17638873 10.1158/0008-5472.CAN-07-0584 1:CAS:528:DC%2BD2sXnslOjtLw%3D
27. J Nishio H Iwasaki M Ishiguro Y Ohjimi C Fujita H Ikegami A Ariyoshi M Naito Y Kaneko M Kikuchi 2003 Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization Int J Oncol 22 3 535 542 12579306
28. ER Hugo TD Brandebourg CE Comstock KS Gersin JJ Sussman N Ben-Jonathan 2006 LS14: a novel human adipocyte cell line that produces prolactin Endocrinology 147 1 306 313 16195405 10.1210/en.2005-0989 1:CAS:528: DC%2BD28XptFCg
29. EL Snyder DJ Sandstrom K Law C Fiore E Sicinska J Brito D Bailey JA Fletcher M Loda SJ Rodig P Dal Cin CD Fletcher 2009 c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme J Pathol 218 3 292 300 19449367 10.1002/path.2564 1:CAS:528:DC%2BD1MXoslOkt78%3D
30. F Persson A Olofsson H Sjogren N Chebbo B Nilsson G Stenman P Aman 2008 Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line Cancer Lett 260 1-2 37 47 18160213 10.1016/j.canlet.2007.10.032 1:CAS:528:DC%2BD1cXosFejsA%3D%3D
31. C Wittekind CC Compton FL Greene LH Sobin 2002 TNM residual tumor classification revisited Cancer 94 9 2511 2516 12015777 10.1002/cncr.10492
32. CD Fletcher 2006 The evolving classification of soft tissue tumours: an update based on the new WHO classification Histopathology 48 1 3 12 16359532 10.1111/j.1365-2559.2005.02284.x 1:STN:280:DC%2BD2Mnnt1yrtA%3D%3D
33. J Limon P Dal Cin AA Sandberg 1986 Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors Cancer Genet Cytogenet 23 4 305 313 3022913 10.1016/0165-4608(86)90013-0 1:STN:280: DyaL2s%2FltFarsw%3D%3D
34. J Bayani M Zielenska P Marrano Y Kwan Ng MD Taylor V Jay JT Rutka JA Squire 2000 Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping J Neurosurg 93 3 437 448 10969942 10.3171/jns.2000.93.3.0437 1:CAS:528:DC%2BD3cXmvVensbw%3D
35. E Schrock S du Manoir T Veldman B Schoell J Wienberg MA Ferguson-Smith Y Ning DH Ledbetter I Bar-Am D Soenksen Y Garini T Ried 1996 Multicolor spectral karyotyping of human chromosomes Science 273 5274 494 497 8662537 10.1126/science.273.5274.494 1:CAS:528:DyaK28Xks1Wmu7w%3D
36. S Jacobs ER Thompson Y Nannya G Yamamoto R Pillai S Ogawa DK Bailey IG Campbell 2007 Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays Cancer Res 67 6 2544 2551 17363572 10.1158/0008-5472. CAN-06-3597 1:CAS:528:DC%2BD2sXivV2nsr4%3D
37. BG Gabrielsson LE Olofsson A Sjogren M Jernas A Elander M Lonn M Rudemo LM Carlsson 2005 Evaluation of reference genes for studies of gene expression in human adipose tissue Obes Res 13 4 649 652 15897472 10.1038/oby.2005.72
38. M Nilbert A Rydholm F Mitelman PS Meltzer N Mandahl 1995 Characterization of the 12q13-15 amplicon in soft tissue tumors Cancer Genet Cytogenet 83 1 32 36 7656201 10.1016/S0165-4608(95)00016-X 1:CAS:528:DyaK2MXoslSgs78%3D
39. JM Berner A Forus A Elkahloun PS Meltzer O Fodstad O Myklebost 1996 Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas Genes Chromosomes Cancer 17 4 254 259 8946207 10.1002/(SICI)1098-2264(199612)17: 4<254::AID-GCC7>3.0.CO;2-2 1:CAS:528:DyaK2sXotlSq
40. B Fritz F Schubert G Wrobel C Schwaenen S Wessendorf M Nessling C Korz RJ Rieker K Montgomery R Kucherlapati G Mechtersheimer R Eils S Joos P Lichter 2002 Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma Cancer Res 62 11 2993 2998 12036902 1:CAS:528:DC%2BD38XksVyrurk%3D
41. AE Horvai S DeVries R Roy RJ O'Donnell F Waldman 2009 Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma Mod Pathol 22 11 1477 1488 19734852 10.1038/modpathol.2009.119 1:CAS:528:DC%2BD1MXhtlegsb%2FL
42. I Hostein M Pelmus A Aurias F Pedeutour S Mathoulin-Pelissier JM Coindre 2004 Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas J Pathol 202 1 95 102 14694526 10.1002/path.1495 1:CAS:528:DC%2BD2cXnslCntA%3D%3D
43. N Sirvent JM Coindre G Maire I Hostein F Keslair L Guillou D Ranchere-Vince P Terrier F Pedeutour 2007 Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR Am J Surg Pathol 31 10 1476 1489 17895748 10.1097/PAS.0b013e3180581fff
44. PB Aleixo AA Hartmann IC Menezes RT Meurer AM Oliveira 2009 Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours J Clin Pathol 62 12 1127 1135 19946100 10.1136/jcp.2009.070201 1:STN:280:DC%2BD1MjovFWkug%3D%3D
45. J Nishio 2011 Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors J Biomed Biotechnol 2011 524067 21274402 10.1155/2011/524067
46. MR Tanas BP Rubin RR Tubbs SD Billings E Downs-Kelly JR Goldblum 2010 Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience Arch Pathol Lab Med 134 12 1797 1803 21128778
47. JJ Manfredi 2010 The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor Genes Dev 24 15 1580 1589 20679392 10.1101/gad.1941710 1:CAS:528:DC%2BC3cXhtVeitrvI
48. KM Muller IH Tveteraas M Aasrum J Odegard M Dawood O Dajani T Christoffersen DL Sandnes 2011 Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells BMC Cancer 11 1 421 21961726 10.1186/1471-2407-11-421 1:CAS:528:DC%2BC3MXhtlGmsLrK
49. J Szymanska M Virolainen M Tarkkanen T Wiklund S Asko-Seljavaara E Tukiainen I Elomaa C Blomqvist S Knuutila 1997 Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study Cancer Genet Cytogenet 99 1 14 18 9352790 10.1016/S0165-4608(96)00436-0 1:CAS:528:DyaK2sXntFCjsLw%3D
50. J Szymanska M Tarkkanen T Wiklund M Virolainen C Blomqvist S Asko-Seljavaara E Tukiainen I Elomaa S Knuutila 1996 Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization Genes Chromosomes Cancer 15 2 89 94 8834171 10.1002/(SICI)1098-2264(199602)15:2<89: :AID-GCC2>3.0.CO;2-# 1:CAS:528:DyaK28Xhs1Sjur8%3D
51. RF Suijkerbuijk DE Olde Weghuis M Van den Berg F Pedeutour A Forus O Myklebost C Glier C Turc-Carel A Geurts van Kessel 1994 Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas Genes Chromosomes Cancer 9 4 292 295 7519052 10.1002/gcc.2870090410 1:STN:280:DyaK2czhvVGksA%3D%3D
52. HR Ashar MS Fejzo A Tkachenko X Zhou JA Fletcher S Weremowicz CC Morton K Chada 1995 Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains Cell 82 1 57 65 7606786 10.1016/0092-8674(95)90052-7 1:CAS:528:DyaK2MXntVCns7s%3D
53. MM Petit R Mols EF Schoenmakers N Mandahl WJ Van de Ven 1996 LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family Genomics 36 1 118 129 8812423 10.1006/geno.1996.0432 1:CAS:528:DyaK28Xlt1agtLs%3D
54. MM Petit EF Schoenmakers C Huysmans JM Geurts N Mandahl WJ Van de Ven 1999 LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes Genomics 57 3 438 441 10329012 10.1006/geno.1999.5778 1:CAS:528:DyaK1MXivFOrsLY%3D
55. JM Berner LA Meza-Zepeda PF Kools A Forus EF Schoenmakers WJ Van de Ven O Fodstad O Myklebost 1997 HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas Oncogene 14 24 2935 2941 9205100 10.1038/sj.onc.1201135 1:CAS:528:DyaK2sXkt1Grtbo%3D
56. LA Meza-Zepeda JM Berner J Henriksen AP South F Pedeutour AB Dahlberg LH Godager D Nizetic A Forus O Myklebost 2001 Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions Genes Chromosomes Cancer 31 3 264 273 11391797 10.1002/gcc.1143 1:CAS:528:DC%2BD3MXkslClsb8%3D
57. H Bartuma KH Hallor I Panagopoulos A Collin A Rydholm P Gustafson HC Bauer O Brosjo HA Domanski N Mandahl F Mertens 2007 Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype Genes Chromosomes Cancer 46 6 594 606 17370328 10.1002/gcc.20445 1:CAS:528:DC%2BD2sXkslGhtr0%3D
58. F Persson Y Andren M Winnes B Wedell A Nordkvist G Gudnadottir R Dahlenfors H Sjogren J Mark G Stenman 2009 High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2 Genes Chromosomes Cancer 48 1 69 82 18828159 10.1002/gcc.20619 1:CAS:528:DC%2BD1cXhsFSnsbvF
59. N Dreux M Marty F Chibon V Velasco I Hostein D Ranchere-Vince P Terrier JM Coindre 2010 Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases Mod Pathol 23 12 1657 1666 20834238 10.1038/modpathol.2010.174 1:CAS:528:DC%2BC3cXhsV2nsr%2FL
60. G Tallini R Vanni G Manfioletti B Kazmierczak G Faa P Pauwels J Bullerdiek V Giancotti H Van Den Berghe P Dal Cin 2000 HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes Lab Invest 80 3 359 369 10744071 10.1038/labinvest.3780040 1:CAS:528:DC%2BD3cXis1egs7Y%3D
61. H Bartuma I Panagopoulos A Collin D Trombetta HA Domanski N Mandahl F Mertens 2009 Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups Mol Cancer 8 36 19508721 10.1186/1476-4598-8-36
62. RD Craver P Fonseca R Carr 2010 Pediatric epithelial salivary gland tumors: spectrum of histologies and cytogenetics at a children's hospital Pediatr Dev Pathol 13 5 348 353 20055685 10.2350/09-05-0654-OA.1
63. L Bianchini E Saada E Gjernes M Marty J Haudebourg I Birtwisle-Peyrottes F Keslair B Chignon-Sicard E Chamorey F Pedeutour 2011 Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data Genes Chromosomes Cancer 50 6 442 455 21412931 10.1002/gcc.20869 1:CAS:528:DC%2BC3MXksVKgtLc%3D
64. C Louis-Brennetot JM Coindre C Ferreira G Perot P Terrier A Aurias 2011 The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis. An analysis of 104 tumors Genes Chromosomes Cancer 50 11 896 907 21910158 10.1002/gcc.20909 1:CAS:528: DC%2BC3MXhtFCmu77J
65. RJ Rieker S Joos C Bartsch F Willeke M Schwarzbach M Otano-Joos S Ohl J Hogel T Lehnert P Lichter HF Otto G Mechtersheimer 2002 Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas Int J Cancer 99 1 68 73 11948494 10.1002/ijc.10287 1:CAS:528:DC%2BD38XivVCgs74%3D
66. T Chaplin O Bernard HB Beverloo V Saha A Hagemeijer R Berger BD Young 1995 The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene Blood 86 6 2073 2076 7662954 1:CAS:528:DyaK2MXotVShtr4%3D
67. S Tanabe SK Bohlander CV Vignon R Espinosa 3rd N Zhao PL Strissel NJ Zeleznik-Le JD Rowley 1996 AF10 is split by MLL and HEAB, a human homolog to a putative Caenorhabditis elegans ATP/GTP-binding protein in an invins(10;11)(p12;q23q12) Blood 88 9 3535 3545 8896421 1:CAS:528: DyaK28XmsFOhu7w%3D
68. SE Dobbins P Broderick B Melin M Feychting C Johansen U Andersson T Brannstrom J Schramm B Olver A Lloyd YP Ma FJ Hosking S Lonn A Ahlbom R Henriksson MJ Schoemaker SJ Hepworth P Hoffmann TW Muhleisen MM Nothen S Moebus L Eisele M Kosteljanetz K Muir A Swerdlow M Simon RS Houlston 2011 Common variation at 10p12.31 near MLLT10 influences meningioma risk Nat Genet 43 9 825 827 21804547 10.1038/ng.879 1:CAS:528:DC%2BC3MXpsFKqs7g%3D
69. S Millevoi K Trombitas B Kolmerer S Kostin J Schaper K Pelin H Granzier S Labeit 1998 Characterization of nebulette and nebulin and emerging concepts of their roles for vertebrate Z-discs J Mol Biol 282 1 111 123 9733644 10.1006/jmbi.1998.1999 1:CAS:528:DyaK1cXmt1aktbk%3D
70. VM Coser C Meyer R Basegio J Menezes R Marschalek MS Pombo-de-Oliveira 2010 Nebulette is the second member of the nebulin family fused to the MLL gene in infant leukemia Cancer Genet Cytogenet 198 2 151 154 20362230 10.1016/j.cancergencyto.2009.12.013 1:CAS:528:DC%2BC3cXktlGjtbY%3D
71. J Lessard G Sauvageau 2003 Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells Nature 423 6937 255 260 12714970 10.1038/nature01572 1:CAS:528:DC%2BD3sXjs1yntbg%3D
72. L Cao J Bombard K Cintron J Sheedy ML Weetall TW Davis 2011 BMI1 as a novel target for drug discovery in cancer J Cell Biochem 112 10 2729 2741 21678481 10.1002/jcb.23234 1:CAS:528:DC%2BC3MXhtFyqt7%2FF